Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Combining physical dermabrasion with chemical peeling is more effective for skin treatment than chemical peeling alone.

Herbal nanocosmeceuticals are more effective and eco-friendly than traditional skincare products.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Consider cultural practices and barriers for effective alopecia areata treatment.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.